Latest AJCC Edition Staging System May Not Be As Effective in Differentiating Survival in Melanoma

An external validation of the American Joint Committee on Cancer (AJCC) 8th edition staging system found that the latest edition maintained a similar prognostic accuracy as its predecessor

BMS’ Opdivo cuts risk of melanoma recurrence

Bristol-Myers Squibb’s Opdivo, which is being investigated as adjuvant treatment after surgery for stage IIIb/c or IV melanoma patients at high risk of recurrence, may significantly cut the risk of patients’ cancer returning at 24 months versus Yervoy.

Nivolumab More Effective Than Ipilimumab in Resected High-Risk Melanoma

Extended follow-up from the CheckMate 238 trial confirmed the superior efficacy of nivolumab compared with ipilimumab in patients with stage III and IV resected melanoma.

T-cell redirection therapy shows durable response for metastatic uveal melanoma

Immunocore Limited presented data from the IMCgp100-102 trial at the American Society of Clinical Oncology meeting that showed a durable response and strong overall survival rate in patients with metastatic uveal melanoma.

Cancer in the News

Feature Articles

Outcome Health Announces Initiative With Melanoma Research Foundation To Raise Skin Cancer Awareness

Outcome Health, which provides health education at the moment of care to improve patient outcomes, announced today an initiative with the Melanoma Research Foundation (MRF), the largest non-profit in the country working exclusively in the area of melanoma.

Read the full story

Posted in Melanoma In The News, Patient Information

Chondroitin and melanoma: How worried should you be?

Chondroitin sulfate is among the most popular supplements in the world.

Read the full story

Posted in Melanoma In The News, Latest News

New treatment strategy exploits acquired vulnerability in drug-resistant melanoma

Cancer cells that develop resistance to drugs pay a price for this by simultaneously developing a new vulnerability.

Read the full story

Posted in Melanoma In The News, Information

Drug-Resistant Melanoma Acquires Exploitable Vulnerability

Cancer cells that develop resistance to one or more drugs will simultaneously develop a new weakness that could feasibly make them susceptible to other anticancer treatments.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories